NCT05813236

Brief Summary

The aim of this study is to prove that Novosyn Quick and Monosyn Quick are equivalent in early wound healing in adult patients undergoing resective periodontal surgery. In order to show equivalence between Novosyn Quick and Monosyn Quick EHS, which is composed of 3 parameters: clinical signs of reepithelization, clinical signs of haemostasis and clinical signs of inflammation, will be calculated for each suture 10 ± 5 days postoperatively and cannot differ more than 2 points. Furthermore, complications, the handling of the suture material, pain, satisfaction of the patient and bacterial contamination of the thread (optional) will also be assessed as secondary objectives.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Jun 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Jun 2023Dec 2026

First Submitted

Initial submission to the registry

April 3, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 14, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

June 28, 2023

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

March 6, 2026

Status Verified

March 1, 2026

Enrollment Period

2.9 years

First QC Date

April 3, 2023

Last Update Submit

March 5, 2026

Conditions

Keywords

Resective periodontal surgery

Outcome Measures

Primary Outcomes (1)

  • early wound healing score (EHS)

    The primary end point in order to evaluate the primary objective of the study will be the determination of early wound healing score (EHS) in patients undergoing resective periodontal surgery. The EHS will be evaluated in 3 parameters: clinical signs of re-epithelization (CSR), clinical signs of haemostasis (CSH), and clinical signs of inflammation (CSI). Zero, 3 or 6 points have been used to evaluate the CSR, whereas 0, 1, or 2 points have been used for both CSH and CSI (Table 3). The summation of these 3 parameters generated the EHS. The EHS for ideal wound healing was 10 points, while the worst possible score was 0 points. An EHS of 0 points was assigned in the presence of suppuration, independently of the ratings for the 3 single parameters.

    10 ± 5 days postoperatively

Secondary Outcomes (12)

  • Number of patients showing postoperative wound dehiscence

    10 ± 5 days postoperatively

  • Number of patients showing postoperative Dentinal hypersensitivity

    10 ± 5 days postoperatively

  • Number of patients showing postoperative Oral candidiasis

    10 ± 5 days postoperatively

  • Number of patients showing postoperative Angular cheilitis

    10 ± 5 days postoperatively

  • Number of patients showing postoperative Swelling

    10 ± 5 days postoperatively

  • +7 more secondary outcomes

Study Arms (2)

Novosyn®

EXPERIMENTAL

Novosyn® Quick is available in a range of gauge sizes and lengths, non-needled or attached to stainless steel needles of varying types and sizes: Novosyn® Quick sutures are available undyed in sizes USP 2 (5 metric) through USP 6-0 (0.7 metric).

Device: Novosyn® in resective periodontal surgery

Monosyn®

ACTIVE COMPARATOR

Monosyn® Quick is a sterile, synthetic, absorbable, monofilament surgical suture material made from a triblock copolymer comprising glycolide (72 %), ε-caprolactone (14 %) and trimethylene carbonate (14 %), which is only available undyed.

Device: Monosyn® in resective periodontal surgery

Interventions

The aim of resective procedures is the re-establishment of a healthy periodontium at a reduced level, accepting as irreversible the destruction that has already occurred. In essence, these procedures are all designed to achieve pocket elimination or reduction by the apical shift of the gingival margin.

Monosyn®

The aim of resective procedures is the re-establishment of a healthy periodontium at a reduced level, accepting as irreversible the destruction that has already occurred. In essence, these procedures are all designed to achieve pocket elimination or reduction by the apical shift of the gingival margin.

Novosyn®

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patient undergoing resective periodontal surgery abd one of the incisions below has been performed:
  • Crestal incision
  • Vertical incision
  • Intrasulcular incision
  • Submarginal incision
  • Written informed consent regarding the data collection for the RCT

You may not qualify if:

  • Emergency surgery.
  • Pregnancy.
  • Breastfeeding
  • Patients taking medication that might affect wound healing.
  • Patients having a condition that might affect wound healing.
  • Patients with hypersensitivity or allergy to the suture material

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Facultat d'Odontologia. Universitat Internacional de Catalunya

Sant Cugat del Vallès, Catalonia, 08195, Spain

RECRUITING

MeSH Terms

Conditions

GingivitisGingival DiseasesPeriodontal Diseases

Condition Hierarchy (Ancestors)

InfectionsMouth DiseasesStomatognathic Diseases

Study Officials

  • Carolina Mor Reinoso, Dra.

    Facultat d'Odontologia. Universitat Internacional de Catalunya

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jaume García López, Dr.

CONTACT

Jose Manuel Molina, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Patients and the observers (assessors) will be blinded to the applied suture material. Patients will not be informed which suture material will be applied. The observers (assessors) who will perform the assessment of the wounds will also be unaware of the applied suture type.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients undergoing resective periodontal surgery will randomly (1:1) receive Novosyn Quick (control group) or Monosyn Quick (treatment group). Randomization will take place intraoperatively through dynamic allocation with minimisation algorithm to a suture group. Randomization will be stratified by study site.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 3, 2023

First Posted

April 14, 2023

Study Start

June 28, 2023

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

March 6, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations